Michael J. Mauro

Hematology

225 Summit Ave
Montvale, NJ 07645

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

Journal: Leukemia

Published: March 30, 2026

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

Journal: Leukemia

Published: March 05, 2026

A plain language summary of how the body processes a lower-dose nilotinib tablet (Danziten™) compared to the existing capsule (Tasigna®).

A plain language summary of how the body processes a lower-dose nilotinib tablet (Danziten™) compared to the existing capsule (Tasigna®).

Journal: Future oncology (London, England)

Published: February 06, 2026

Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.

Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 07, 2025

Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia.

Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia.

Journal: Nature reviews. Clinical oncology

Published: July 30, 2025

Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY.

Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY.

Journal: Leukemia & lymphoma

Published: June 23, 2025

How I treat advanced phases of CML.

How I treat advanced phases of CML.

Journal: Blood

Published: June 16, 2025

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Journal: Leukemia

Published: May 29, 2025

Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.

Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.

Journal: Leukemia

Published: February 21, 2025

Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results.

Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results.

Journal: Leukemia

Published: February 14, 2025

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Journal: Blood advances

Published: February 03, 2025

Pharmacokinetic profile of novel reduced-dose Danziten™ (nilotinib tablets) versus Tasigna® (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysis.

Pharmacokinetic profile of novel reduced-dose Danziten™ (nilotinib tablets) versus Tasigna® (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysis.

Journal: Cancer chemotherapy and pharmacology

Published: November 15, 2024

Showing 1-12 of 126

Last Updated: 09/26/2026